Annual SGA
$27.00 M
-$2.95 M-9.85%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual SGA is $27.00 million, with the most recent change of -$2.95 million (-9.85%) on December 31, 2023.
- During the last 3 years, XLO annual SGA has risen by +$16.34 million (+153.42%).
- XLO annual SGA is now -9.85% below its all-time high of $29.95 million, reached on December 31, 2022.
Performance
XLO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$6.31 M
+$492.00 K+8.46%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly SGA is $6.31 million, with the most recent change of +$492.00 thousand (+8.46%) on September 30, 2024.
- Over the past year, XLO quarterly SGA has dropped by -$87.00 thousand (-1.36%).
- XLO quarterly SGA is now -24.07% below its all-time high of $8.31 million, reached on June 30, 2022.
Performance
XLO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.40 B
-$62.80 M-4.71%
September 30, 2024
Summary
- As of February 8, 2025, XLO TTM SGA is -$1.40 billion, with the most recent change of -$62.80 million (-4.71%) on September 30, 2024.
- Over the past year, XLO TTM SGA has dropped by -$1.42 billion (-5269.19%).
- XLO TTM SGA is now -1540.14% below its all-time high of -$85.09 million.
Performance
XLO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
XLO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.8% | -1.4% | -5269.2% |
| 3 y3 years | +153.4% | -1.4% | -5269.2% |
| 5 y5 years | - | -1.4% | -5269.2% |
XLO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.8% | +13.2% | -24.1% | +8.5% | -226.8% | at low |
| 5 y | 5-year | -9.8% | +465.9% | -24.1% | +115.4% | -1540.1% | at low |
| alltime | all time | -9.8% | +465.9% | -24.1% | +115.4% | -1540.1% | at low |
Xilio Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.31 M(+8.5%) | $24.66 M(-0.0%) |
| Jun 2024 | - | $5.82 M(-5.3%) | $24.66 M(-4.2%) |
| Mar 2024 | - | $6.14 M(-4.0%) | $25.74 M(-4.7%) |
| Dec 2023 | $27.00 M(-9.9%) | $6.39 M(+1.3%) | $27.00 M(-6.2%) |
| Sep 2023 | - | $6.31 M(-8.5%) | $28.77 M(-2.9%) |
| Jun 2023 | - | $6.90 M(-6.7%) | $29.63 M(-4.5%) |
| Mar 2023 | - | $7.39 M(-9.5%) | $31.04 M(+3.6%) |
| Dec 2022 | $29.95 M | $8.17 M(+14.0%) | $29.95 M(-0.1%) |
| Sep 2022 | - | $7.17 M(-13.7%) | $29.98 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $8.31 M(+31.8%) | $28.30 M(+12.1%) |
| Mar 2022 | - | $6.30 M(-23.2%) | $25.26 M(+5.9%) |
| Dec 2021 | $23.86 M(+123.9%) | $8.20 M(+49.4%) | $23.86 M(+28.4%) |
| Sep 2021 | - | $5.49 M(+4.4%) | $18.58 M(+14.3%) |
| Jun 2021 | - | $5.26 M(+7.4%) | $16.25 M(+47.9%) |
| Mar 2021 | - | $4.90 M(+67.3%) | $10.99 M(+80.4%) |
| Dec 2020 | $10.65 M(+123.3%) | $2.93 M(-7.4%) | $6.09 M(+92.6%) |
| Sep 2020 | - | $3.16 M | $3.16 M |
| Dec 2019 | $4.77 M | - | - |
FAQ
- What is Xilio Therapeutics annual SGA?
- What is the all time high annual SGA for Xilio Therapeutics?
- What is Xilio Therapeutics annual SGA year-on-year change?
- What is Xilio Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly SGA year-on-year change?
- What is Xilio Therapeutics TTM SGA?
- What is the all time high TTM SGA for Xilio Therapeutics?
- What is Xilio Therapeutics TTM SGA year-on-year change?
What is Xilio Therapeutics annual SGA?
The current annual SGA of XLO is $27.00 M
What is the all time high annual SGA for Xilio Therapeutics?
Xilio Therapeutics all-time high annual SGA is $29.95 M
What is Xilio Therapeutics annual SGA year-on-year change?
Over the past year, XLO annual SGA has changed by -$2.95 M (-9.85%)
What is Xilio Therapeutics quarterly SGA?
The current quarterly SGA of XLO is $6.31 M
What is the all time high quarterly SGA for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly SGA is $8.31 M
What is Xilio Therapeutics quarterly SGA year-on-year change?
Over the past year, XLO quarterly SGA has changed by -$87.00 K (-1.36%)
What is Xilio Therapeutics TTM SGA?
The current TTM SGA of XLO is -$1.40 B
What is the all time high TTM SGA for Xilio Therapeutics?
Xilio Therapeutics all-time high TTM SGA is -$85.09 M
What is Xilio Therapeutics TTM SGA year-on-year change?
Over the past year, XLO TTM SGA has changed by -$1.42 B (-5269.19%)